Form 4 · Filed May 26, 2026, 09:48 PM UTC
BCAX/Bicara Therapeutics Inc.
Hyep Ivan — Chief Financial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 21, 2026 | M | other | 9,200 | $4 | $34,866 | 154,555 |
| May 21, 2026 | S | sell | 9,200 | $20 | $187,883 | 145,355 |
| May 21, 2026 | M | other | 9,200 | — | — | 70,584 |
Source: SEC EDGAR raw filing ↗ · Accession 0001628280-26-038248